Skip to main content

WIndow Therapeutics

Boston, United States

WIndow Therapeutics discovers and develops transformational therapeutics for cancer.

$256K raised
Feb 2022
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about WIndow Therapeutics

How much funding has WIndow Therapeutics raised?
WIndow Therapeutics has raised $256K in total funding. The most recent round was Grant. The last funding was announced in February 2022.
Who are WIndow Therapeutics's investors?
WIndow Therapeutics's investors include National Science Foundation.
Where is WIndow Therapeutics headquartered?
WIndow Therapeutics is headquartered in Boston, United States.
What does WIndow Therapeutics do?
WIndow Therapeutics discovers and develops transformational therapeutics for cancer.
What stage is WIndow Therapeutics at?
WIndow Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"WIndow Therapeutics — Funding & Investors." VCBacked, February 24, 2022, https://www.vcbacked.co/company/window-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). WIndow Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/window-therapeutics
Wikipedia (cite web)
{{cite web |title=WIndow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/window-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .